Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	0.38	-24.67	24.58
Graham Fair Price	15.00	19857.28	17266.82
PEG	139.39	< 0.005	< 0.005
Price/Book	-7.50	0.21	0.23
Price/Cash Flow	870.70	10.97	1.13
Prices/Earnings	-37.48	-1.71	2.73
Price/Sales	9.43	0.28	0.25
Price/FCF	870.70	10.97	1.13
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-89.40	< 0.005	0.08
Operating Margin	155.13	-0.06	0.02
ROA	34.45	< 0.005	< 0.005
ROE	0.02	-0.03	47.94
ROIC	0.02	-0.02	16.25
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	-0.05	72.27
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	30.33	-3.05	-89.96
EPS QOQ	9.18	-2.40	-73.88
FCF QOQ	2.93	-0.91	-68.92
Revenue QOQ	0.07	-0.20	176.78
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	30.49	33.76	10.71
Days Sales Outstanding (DSO)	98.71	140.16	41.99
Inventory Turnover	2.95	2.67	-9.67
Debt/Capitalization	0.47	0.48	2.24
Quick Ratio	0.73	0.71	-2.71
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	25181.16	23809.19	-5.45
Cash	7336.49	6360.77	-13.30
Capex	-165.43	-16.36	90.11
Free Cash Flow	5077.31	457.45	-90.99
Revenue	22640.09	18093.89	-20.08
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.34	1.28	-4.49
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	18.45	-19.52	5.81
Naive Interpretation	Member

06 - Financial Health · Weak

Rating